Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Patient safety

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

9 results

Sort by

List item

Human medicine European public assessment report (EPAR): Xeljanz (updated)

tofacitinib citrate, Arthritis, Rheumatoid
Date of authorisation: 21/03/2017,
Date of refusal: 25/04/2013, , , Revision: 18, Authorised, Last updated: 08/06/2021
List item

Human medicine European public assessment report (EPAR): Capecitabine Accord (updated)

capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012, , , Revision: 14, Authorised, Last updated: 04/06/2021
List item

Human medicine European public assessment report (EPAR): Lemtrada (updated)

alemtuzumab, Multiple Sclerosis
Date of authorisation: 12/09/2013, , , Revision: 12, Authorised, Last updated: 25/05/2021
List item

Human medicine European public assessment report (EPAR): Ecansya (previously Capecitabine Krka)

capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012, , , Revision: 13, Authorised, Last updated: 23/04/2021
List item

Human medicine European public assessment report (EPAR): Capecitabine Teva

capecitabine, Colonic Neoplasms, Breast Neoplasms, Colorectal Neoplasms, Stomach Neoplasms
Date of authorisation: 20/04/2012, , , Revision: 14, Authorised, Last updated: 17/03/2021
List item

Human medicine European public assessment report (EPAR): Capecitabine Medac

capecitabine, Colorectal Neoplasms
Date of authorisation: 19/11/2012, , , Revision: 11, Authorised, Last updated: 10/03/2021
List item

Human medicine European public assessment report (EPAR): Gilenya

fingolimod hydrochloride , Multiple Sclerosis
Date of authorisation: 17/03/2011, , , Revision: 28, Authorised, Last updated: 04/02/2021
List item

Human medicine European public assessment report (EPAR): Xarelto

rivaroxaban, Arthroplasty, Replacement, Venous Thromboembolism
Date of authorisation: 30/09/2008, , , Revision: 33, Authorised, Last updated: 02/02/2021
List item

Human medicine European public assessment report (EPAR): Picato

Ingenol mebutate, Keratosis, Actinic
Date of authorisation: 15/11/2012, , , Revision: 10, Withdrawn, Last updated: 31/07/2020